The global virtual 3D nanorobots market is presumed to witness an increasing growth over the forecast period owing to the technological innovations, advancement in healthcare infrastructure in developed countries, the introduction of advanced medical equipment, and increasing awareness among the clientele.
Growth in the volume of ailments, as a repercussion of rising disease prevalence levels, is also expected to drive virtual 3D nanorobots market growth. Longevity due to the presence of worldly healthcare infrastructure and rising disposable income levels are expected to be the key drivers for popularity.
Although substantial breakthroughs have been made, there is still much work to be implemented before the concept becomes reality. The potential of a new integrative field of science is expected to inspire many governments to dedicate significant resources to nanotechnology and prototype testing.
The U.S. National Science Foundation has launched an initiative, “Scientific Visualization,” to create awareness using supercomputers in depicting the technology to the world. As stated by the U.S. National Science Foundation, the virtual 3D nanorobots market is expected to exceed USD 1 trillion by 2015.
Market players have resorted to technological innovations to create state-of-the-art technologies as well as develop new applications for contemporary platforms, which are expected to drive the demand. The virtual 3D nanorobots industry is observing a growing trend of companies to build nanorobots.
Firms are collaborating on technology platforms to develop new nanoproducts. Increasing the adoption of technologically advanced systems is expected to drive popularity. The virtual 3D nanorobots industry possesses significant opportunities due to the fact that nanorobots are useful in monitoring, diagnosing, and fighting sickness as well as curing HIV, cancer, and other harmful diseases. Moreover, they are also useful in treating and finding diseases and restoring the lost tissues at a cellular level.
Key medical applications include dentistry, brain aneurysm, cancer detection and treatment, gene therapy, surgery, and nanomedicine.
Applications of virtual 3D nanorobots in dentistry include tooth durability and appearance, major tooth repair, and impression. In the case of a brain aneurysm, nanobots are used to track the chemical concentration and identify the brain aneurysm at an early stage. Nanobots with embedded chemical biosensors are used to detect cancer cells at the early stages of development and treat cancer.
Nanobots treat genetic diseases by comparing the molecular structure of both proteins and DNA in the cells. Irregularities are then corrected and modifications are performed. Surgical nanobots are introduced in the body and they act as an on-site surgeon inside the human body.
Nanorobotics in medicine includes drug delivery for cancer cells, monitoring of diabetes, and curing several healthcare problems. Nanobots migrate white blood cells to reach inflamed tissues, which in turn help in the healing process.
The virtual 3D nanorobots market is considerably advanced and is expected to include the addition of operational and statistical research for higher performance, nanomachine design, and simulation of the new environment. By merging new technologies with operational nanomachines, the industry is expected to go hand in hand with advancement.
Virtual 3D nanorobots are still in the research and development phase. Many attempts are being made for the successful accomplishment of these nanomachines.
In March 2015, a team at Harvard’s Wyss Institute in Massachusetts developed virtual 3D nanorobots that are expected to treat a leukemia patient with just months to live. These nanobots were made from DNA strands and they carried a payload of drugs.
In April 2015, researchers at the University of Montreal developed magnetic nanoparticles to open the blood-brain barrier and deliver chemical molecules directly into the brain. This is expected to remove the brain tumors without performing surgery.
In July 2015, scientists from Israel and Switzerland reported the development of a virtual 3D nanorobot that can swim through human body fluids to deliver drugs to target organs. The movement of nanorobot is controlled by applying the oscillating magnetic field.
In May 2015, Pfizer collaborated with the robot laboratory managed by Prof. Ido Bachelet at Bar-Ilan University. Bachelet developed a method of producing innovative DNA molecules with characteristics that can be used to program them to each specific location in the body and carry out pre-programmed operations.
In June 2015, researchers at Drexel University announced a partnership of 11 institutions worldwide in developing a corkscrew-shaped nanorobot that will be able to drill through blocked arteries.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.